CLC (Gene)

Organism:

Homo sapiens

Synonyms:CLC, Charcot-Leyden crystal galectin, ENTREZ:1178, GAL10, Gal-10, HGNC:2014, LGALS10, LGALS10A, LPPL_HUMAN, MIM:153310, NM_001828, NP_001819

Omim:OMIM:153310

Id:efb18a49-c2f0-5815-b8e1-c9db65d090b6

Hgnc:HGNC:2014

Entrez:1178

Ensembl:ENSG00000105205

Description:Charcot-Leyden crystal galectin

Analyze

CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View CLC's neighborhood in the knowledge graph.

Submit

Playbook Workflow Builder: Gene-Centric Workflow

View Gene-Centric information about the gene from a pre-built PWB workflow. View the workflow with CLC.

CFDE Gene-Centric Appyter

The CFDE Gene Centric Appyter Resolves and Displays Gene-Centric information from CFDE APIs. Execute the Appyter using CLC.

Submit

GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for CLC.

Submit

Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with CLC.

Results found

Linked to

	Label	Description
	GSE238213 dopamine 2 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE129698 SYK inhibition 6 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182150 KIT LSD1 MYC inhibition 6 v 7 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE183327 GSE183328 DDIT3 overexpression 1 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239688 canagliflozin 4 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE155031 catechin SH-SY5Y 5 v 0 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE68925 fasudil 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE150049 dexamethasone 2 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE76425 lenalidomide 0 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS

GSE238213 dopamine 2 v 4 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE129698 SYK inhibition 6 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE182150 KIT LSD1 MYC inhibition 6 v 7 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE183327 GSE183328 DDIT3 overexpression 1 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE239688 canagliflozin 4 v 1 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE155031 catechin SH-SY5Y 5 v 0 human up

Gene Set (Entity type)

A Gene Set from LINCS

GSE68925 fasudil 1 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE150049 dexamethasone 2 v 0 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE76425 IKZF1 CRBN MEIS2 IKZF3 inhibition Lenalidomide 0 v 5 human dn

Gene Set (Entity type)

A Gene Set from LINCS

GSE76425 lenalidomide 0 v 5 human dn

Gene Set (Entity type)

A Gene Set from LINCS

DISPLAY PER PAGE

CFDE Workbench

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

CFDE Workbench

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.